Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
529.30
-16.82 (-3.08%)
Streaming Delayed Price
Updated: 2:27 PM EDT, Sep 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
503,476
Open
529.64
Bid (Size)
529.01 (120)
Ask (Size)
529.38 (40)
Prev. Close
546.12
Today's Range
520.20 - 535.00
52wk Range
374.17 - 560.25
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Where Will CRISPR Therapeutics Stock Be in 5 Years?
↗
Today 11:20 EDT
CRISPR's expanding pipeline could unlock significantly more value by 2031.
Via
The Motley Fool
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
Today 9:00 EDT
A look at the three approaches competing to help beta cell replacement survive the immune system
From
Biotech Insider
Via
GlobeNewswire
Performance
YTD
+17.1%
+17.1%
1 Month
+1.0%
+1.0%
3 Month
+19.5%
+19.5%
6 Month
+14.8%
+14.8%
1 Year
+33.9%
+33.9%
More News
Read More
3 Market-Beating Stocks for Long-Term Investors
Today 0:35 EDT
Via
StockStory
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
↗
September 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
↗
September 04, 2026
Via
Benzinga
3 Stocks Whose Competitive Walls Tower Over Nvidia's
↗
September 03, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026
↗
September 02, 2026
Via
The Motley Fool
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
September 01, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
August 31, 2026
Via
StockStory
Topics
Stocks
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
↗
August 27, 2026
Via
Benzinga
Vertex to Participate in Upcoming September Investor Conferences
August 26, 2026
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 Large-Cap Stocks to Research Further and 1 We Question
August 26, 2026
Via
StockStory
Inflation Is Rising Again. History Says These 2 Stocks Are Among the Smartest Places to Hide
↗
August 24, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?
↗
August 21, 2026
Via
The Motley Fool
CRISPR Therapeutics Stock Is Up Only 8% This Year. Is Cathie Wood's Bet on the Gene-Editing Stock Dead Money?
↗
August 21, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Uber, ServiceNow And A Health Care Stock On CNBC’s ‘Final Trades’
↗
August 21, 2026
Via
Benzinga
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
↗
August 20, 2026
Via
The Motley Fool
3 Cash-Producing Stocks on Our Watchlist
August 18, 2026
Via
StockStory
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
↗
August 14, 2026
Via
The Motley Fool
$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
↗
August 14, 2026
Via
Benzinga
Vertex (VRTX) Q2 2026 Earnings Call Transcript
↗
August 10, 2026
Via
The Motley Fool
Topics
Earnings
Discover which S&P500 stocks are making waves on Monday.
↗
August 10, 2026
Via
Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
↗
August 10, 2026
Via
Chartmill
Get insights into the top movers in the S&P500 index of Monday's pre-market session.
↗
August 10, 2026
Via
Chartmill
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
August 10, 2026
Via
StockStory
Topics
Earnings
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 529.30
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 09/08/26 02:27 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 137.32B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 137B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.